- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alembic Pharmaceuticals Limited — Updates, 12-06-2026: Press Release
12-06-2026 | 12:43 pm
12-06-2026 | 12:43 pm
Alembic Pharma received USFDA approval for Tretinoin Cream USP, 0.05%, for acne treatment. This product targets an estimated US$ 76 million market, expanding Alembic's US presence.
No comments yet. Be the first to comment!